Skip to content

Evogliptin Impurity R7

Evogliptin Impurity R7

Product Description
CAT No.
ALN-E047008
CAS No.
NA
Mol. F.
C19H27F2N3O3 : C4H6O6
Mol. Wt.
383.4 : 150.1
Stock
Please Inquire
RFQ
Chemical Name : [(R)-4- {(R)-3-Amino-4-(3,4- difluorophenyl)butanoyl }-3-(tbutoxymethyl) piperazin- 2-one L-tartrate]
Smiles : O[C@H]([C@H](C(O)=O)O)C(O)=O.O=C1NCCN(C(C[C@H](N)CC2=CC=C(F)C(F)=C2)=O)[C@@H]1COC(C)(C)C
Inchi : InChI=1S/C19H26F3N3O3.C4H6O6/c1-19(2,3)28-10-15-18(27)24-6-7-25(15)16(26)9-11(23)8-12-13(20)4-5-14(21)17(12)22;5-1(3(7)8)2(6)4(9)10/h4-5,11,15H,6-10,23H2,1-3H3,(H,24,27);1-2,5-6H,(H,7,8)(H,9,10)/t11-,15-;1-,2-/m11/s1

Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice

Yu-Na Chae, Tae-Hyoung Kim, Mi-Kyung Kim, Chang-Yell Shin, Il-Hoon Jung, Yong Sung Sohn, and Moon-Ho SonnPLoS One. 2015; 10(12): e0144064.

Request For Quotation

Related Products